Andrew Moshfeghi, MD, MBA

Associate Professor of Clinical Ophthalmology

Director of Clinical Trials

Medical Director, USC Roski Eye Institute

Vice Chair for Clinical Affairs, Department of Ophthalmology

Image of Andrew Moshfeghi, MD, MBA
Is this your profile? Click to edit

Overview

Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following completion of his residency in ophthalmology, Dr. Moshfeghi attended the prestigious Bascom Palmer Eye Institute for his fellowship training in medial retina and vitreoretinal surgery and diseases. He also graduated from the University of Miami Graduate School of Business Administration with an MBA specializing in Health Sector Policy and Management.

Dr. Andrew A. Moshfeghi serves as an associate professor of clinical ophthalmology, director of Clinical Trials, and director of the Medical Retina and Surgical Retina Fellowship Programs at USC. He is a recognized expert in diseases of the vitreous, retina, and macula. He formerly served as associate professor of Ophthalmology and medical director at the Bascom Palmer Eye Institute at the University of Miami. Dr. Moshfeghi is a noted vitreoretinal surgeon.

Dr. Moshfeghi’s research concentrates on evaluation of intraocular pharmacotherapeutics, application of novel ophthalmic imaging techniques, and assessing health care utilization trends.

Awards

  • American Society of Retina Specialists: ASRS Honor Award, 2015
     – 2015
  • American Academy of Ophthalmology: AAO Achievement Award, 2013
     – 2013
  • Castle Connolly Top Doctors: Top Doctors Award, 2012
     – 2015
  • The Best Doctors in America: Best Doctors Award, 2009
     – 2015
  • University of Miami Graduate School of Business Administration, Executive MBA Program in Health Sect: Award of Academic Merit, 2009
  • University of Miami School of Business Administration Program in Health Sector Policy & Management: Full-Tuition Competitive Scholarship for Executive MBA, 2007
     – 2009
  • Ronald G Michels Fellowship Foundation: Ronald G. Michels Fellowship Foundation Award, 2005
     – 2006
  • Tulane University School of Medicine: James H. Allen Award for Excellence in Ophthalmology, 1998
     – 1999
  • The University of Chicago Small School Talent Search Scholar, 1991
     – 1995

Education and Training

  • Tulane University School of Medicine — MD — 1999
  • University of Miami Graduate School of Business Administration — MBA- Health Sector Policy and Management — 2009
  • North Shore University Hospital, New York University School of Medicine — Ophthalmology Residency — 2003
  • University of Miami Bascom Palmer Eye Institute — Medical Retina Fellowship — 2004
  • University of Miami Bascom Palmer Eye Institute — Vitreoretinal Surgery & Diseases Fellowship — 2006

Publications

  • Universal Newborn Eye Screening in São Paulo, Brazil. Ophthalmic Surg Lasers Imaging Retina. 2026 May; 57(5):334-337.. View in PubMed
  • The Association of Retinal Capillary Density and Retinal Thickness in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025 11 03; 66(14):3.. View in PubMed
  • Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice. BMC Ophthalmol. 2024 May 31; 24(1):229.. View in PubMed
  • Comparison of The Results of Sponsored Genetic Testing Panels for Inherited Retinal Diseases. J Clin Med. 2024 May 26; 13(11).. View in PubMed
  • Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States. Sci Rep. 2023 06 09; 13(1):9430.. View in PubMed
  • Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy. BMJ Open Ophthalmol. 2023 03; 8(1).. View in PubMed
  • Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2022 Jul; 260(7):2191-2200.. View in PubMed
  • Capillary density and caliber as assessed by optical coherence tomography angiography may be significant predictors of diabetic retinopathy severity. PLoS One. 2022; 17(1):e0262996.. View in PubMed
  • FAILED LASER RETINOPEXY IN A PATIENT UNDERGOING PAZOPANIB THERAPY. Retin Cases Brief Rep. 2021 Nov 01; 15(6):752-755.. View in PubMed
  • Relating Retinal Vascular Oxygen Saturation and Microvasculature Morphology at Progressive Stages of Diabetic Retinopathy. Transl Vis Sci Technol. 2021 05 03; 10(6):4.. View in PubMed